NCT06032754Completed
PortoSinusoidal Vascular Diseases and Systemic Sclerosis
Source: ClinicalTrials.gov · Last updated 20 Jun 2024
Brief summary (registry, in English)
Porto-Sinusoidal Vascular Disorders (PSVD) is a heterogeneous clinico-pathological entity characterized by alterations in small liver vessels. "Nodular regenerative hyperplasia (NRH)" is the most common PSVD. The most frequent liver disease associated with Systemic sclerosis (SSc) is primary biliary cholangitis reported in 2 to 22% of cases. NRH prevalence estimated to 1.4%, may be underestimated as NRH diagnosis is histologic and usually suspected in case of complications due to portal hypertension. Few data are available about NRH associated with SSc resulting in a lack of knowledge of the characteristics and outcome of these patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 180 (actual)
- First submitted
- 5 Sept 2023
- Start date
- 1 Feb 2023
- Primary completion date
- 29 Mar 2024
- Lead sponsor
- University Hospital, Caen
- Diseases
- Systemic sclerosis (scleroderma)
- NCT number
- NCT06032754
What you commit to
- Study type: Observational
- Participants enrolled: 180
- From 1 Feb 2023 to the primary completion date, 29 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Autoimmune hepatitis
Other
- Liver cirrhosis
- Limited scleroderma
- Primary biliary cholangitis
Who the study is looking for
- PSVD (Valdig criteria)
- SSC (ACR/EULAR 2013 criteria)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de CAEN Coordinator of this site? Confirm its status | Caen | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.